FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in millions, except per share amounts)

Three Months Ended

Twelve Months Ended

December 31

December 31

2015

2014

2015

2014

Revenue

$

899.3

$

887.8

$

3,276.5

$

3,258.7

Costs of sales and services

600.7

569.5

2,201.1

2,047.8

Gross margin

298.6

318.3

1,075.4

1,210.9

Selling, general and administrative expenses

147.0

214.9

737.9

589.8

Research and development expenses

40.9

37.8

143.7

126.3

Restructuring and other charges (income)

165.8

11.5

244.0

56.4

Business separation costs

—

—

—

23.6

Total costs and expenses

954.4

833.7

3,326.7

2,843.9

Income (loss) from operations

(55.1)

54.1

(50.2)

414.8

Equity in (earnings) loss of affiliates

0.2

—

0.2

(0.2)

Interest expense, net

21.2

13.6

80.1

51.2

Income (loss) from continuing operations before income taxes

(76.5)

40.5

(130.5)

363.8

Provision (benefit) for income taxes

103.8

(18.4)

47.4

56.2

Income (loss) from continuing operations

(180.3)

58.9

(177.9)

307.6

Discontinued operations, net of income taxes

(22.4)

19.4

676.4

14.5

Net income (loss)

$

(202.7)

$

78.3

$

498.5

$

322.1

  Less: Net income attributable to noncontrolling interests

1.4

1.8

9.5

14.6

Net income (loss) attributable to FMC stockholders

$

(204.1)

$

76.5

$

489.0

$

307.5

Amounts attributable to FMC stockholders:

  Income (loss) from continuing operations, net of tax

$

(181.7)

$

57.1

$

(187.4)

$

298.2

  Discontinued operations, net of tax

(22.4)

19.4

676.4

9.3

  Net income (loss)

$

(204.1)

$

76.5

$

489.0

$

307.5

Basic earnings (loss) per common share attributable to FMC stockholders:

  Continuing operations

$

(1.36)

$

0.43

$

(1.40)

$

2.23

  Discontinued operations

(0.17)

0.14

5.06

0.07

  Basic earnings per common share

$

(1.53)

$

0.57

$

3.66

$

2.30

Average number of shares outstanding used in basic earnings per share computations

133.7

133.5

133.7

133.3

Diluted earnings (loss) per common share attributable to FMC stockholders:

 Continuing operations

$

(1.36)

$

0.43

$

(1.40)

$

2.22

 Discontinued operations

(0.17)

0.14

5.06

0.07

 Diluted earnings per common share

$

(1.53)

$

0.57

$

3.66

$

2.29

Average number of shares outstanding used in diluted earnings per share computations

133.7

134.3

133.7

134.3

Other Data:

Capital additions

$

42.5

$

53.7

$

118.6

$

174.8

Depreciation and amortization expense

$

23.5

$

22.6

$

115.7

$

93.5

FMC CORPORATION

SCHEDULE OF ADJUSTED EARNINGS FROM CONTINUING OPERATIONS (NON-GAAP)⁽²⁾

(Unaudited, in millions, except per share amounts)

Three Months Ended

Twelve Months Ended

December 31

December 31

2015

2014

2015

2014

Revenue

$

899.3

$

887.8

$

3,276.5

$

3,258.7

Costs of sales and services

591.0

569.5

2,143.3

2,043.6

Gross margin

308.3

318.3

1,133.2

1,215.1

Selling, general and administrative expenses

125.0

117.5

470.1

447.5

Research and development expenses

40.9

37.8

143.7

126.3

Equity in (earnings) loss of affiliates

0.2

—

0.2

(0.2)

Total costs and expenses

757.1

724.8

2,757.3

2,617.2

Adjusted earnings from continuing operations, before interest, income
taxes and noncontrolling interests (Non-GAAP) ⁽¹⁾

$

142.2

$

163.0

$

519.2

$

641.5

Interest expense, net

21.2

13.6

80.1

51.2

Adjusted earnings from continuing operations, before income taxes and noncontrolling interests

$

121.0

$

149.4

$

439.1

$

590.3

Provision for income taxes

15.8

33.3

97.0

154.1

Net income attributable to noncontrolling interests

1.4

1.8

9.5

9.4

Adjusted after-tax earnings from continuing operations, attributable to FMC stockholders (Non-GAAP) ⁽²⁾

$

103.8

$

114.3

$

332.6

$

426.8

Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders

$

0.77

$

0.85

$

2.47

$

3.18

Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations ⁽³⁾

134.3

134.3

134.4

134.3

___________________

(1)

Referred to as Adjusted Operating Profit.

(2)

The Company believes that the Non-GAAP financial measure "Adjusted After-Tax Earnings from Continuing Operations, attributable to FMC Stockholders", and its presentation on a per share basis, provides useful information about the Company's operating results to investors. Adjusted Earnings excludes the effects of Corporate special charges, Non-GAAP tax adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying businesses from period to period. Additionally, the above schedule is presented in a format which reflects the manner in which we manage our business and is not in accordance with GAAP.

(3)

The average number of shares outstanding used in the twelve months ended December 31, 2015 diluted adjusted after-tax earnings from continuing operations per share computation (Non-GAAP) includes 0.7 million diluted shares. This number of shares differs from the average number of shares outstanding used in diluted earnings per share computations (GAAP) as we had a net loss from continuing operations attributable to FMC stockholders.

FMC CORPORATION

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP)

TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS,

ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP)

(Unaudited, in millions, except per share amounts)

Three Months Ended

Twelve Months Ended

December 31

December 31

2015

2014

2015

2014

Net income (loss) attributable to FMC stockholders (GAAP)

$

(204.1)

$

76.5

$

489.0

$

307.5

Corporate special charges (income):

Restructuring and other charges (income) ^(a)

165.8

11.5

244.0

56.4

Non-operating pension and postretirement charges ^(b)

15.4

2.1

35.3

10.5

Business separation costs ^(c)

—

—

—

23.6

Acquisition-related charges ^(d)

16.3

95.3

290.3

136.0

Income tax expense (benefit) on Corporate special charges (income)

(31.0)

(43.3)

(144.9)

(84.1)

Discontinued operations attributable to FMC stockholders, net of income taxes ^(e)

22.4

(19.4)

(676.4)

(9.3)

Non-GAAP tax adjustments ^(f)

119.0

(8.4)

95.3

(13.8)

Adjusted after-tax earnings from continuing operations attributable to
FMC stockholders (Non-GAAP)

$

103.8

$

114.3

$

332.6

$

426.8

Diluted earnings per common share (GAAP)

$

(1.53)

$

0.57

$

3.66

$

2.29

Corporate special charges (income) per diluted share, before tax:

Restructuring and other charges (income)

1.24

0.08

1.82

0.42

Non-operating pension and postretirement charges

0.11

0.02

0.26

0.08

Business separation costs

—

—

—

0.17

Acquisition-related charges

0.12

0.71

2.16

1.01

Income tax expense (benefit) on Corporate special charges (income), per diluted share

(0.23)

(0.32)

(1.08)

(0.62)

Discontinued operations per diluted share

0.17

(0.15)

(5.06)

(0.07)

Non-GAAP tax adjustments per diluted share

0.89

(0.06)

0.71

(0.10)

Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders (Non-GAAP)

$

0.77

$

0.85

$

2.47

$

3.18

Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations

134.3

134.3

134.4

134.3

____________________

(a) 

Three Months Ended December 31, 2015:

Restructuring and other charges (income) include a charge of $70.5 million as a result of the mothballing of our Seal Sands Omega-3 production facility within Health and Nutrition, as well as $61.8 million of charges representing severance and asset write-offs associated with the integration of Cheminova within Agricultural Solutions.  Amount also include $10.7 million as a result of the Argentina government's action to devalue its currency effective December 17, 2015.  This loss relates to the impacts of the remeasurement of the local balance sheet at the date of the devaluation and impacted both our Agricultural Solutions and Lithium segments. Finally, the amount includes charges from continuing environmental sites treated as a Corporate charge of $13.4 million, a charge of $5.5 million associated with an agreement to obtain certain technology and intellectual property rights related to new compounds still under development within Agricultural Solutions and net miscellaneous charges of $3.9 million.

Three Months Ended December 31, 2014:

Restructuring and other charges (income) includes income of $26.6 million associated with a sale of a partial stake in our 20% owned European based distribution company offset by a charge of $5.0 million associated with a license agreement entered into for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development both of which pertain our FMC Agricultural Solutions segment. Additionally, this amount includes charges of $8.1 million associated with a reorganization of our Health and Nutrition segment and continuing environmental sites treated as a Corporate charge of $23.7 million. Remaining restructuring and other charges (income) includes net miscellaneous charges of $1.3 million.

Twelve Months Ended December 31, 2015:

Restructuring and other charges (income) include a charge of $70.5 million as a result of mothballing of our Seal Sands Omega-3 production facility within Health and Nutrition as well as $117.3 million representing severance and asset disposal charges associated with the integration of Cheminova with Agricultural Solutions.  Charges also include $23.6 million due to a reorganization with our FMC Health and Nutrition segment, of which, $12.3 million was due to the sale of our pectin manufacturing business.  Total charges also include the $10.7 million due to the Argentina currency devaluation, $21.7 million from continuing environmental sites treated as a Corporate charge, and $20.5 million associated with two separate license agreements entered into for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development within Agricultural Solutions.  Partially offsetting these charges was other income associated with the sale of our remaining ownership interest in a Belgian-based pesticide distribution company for $26.6 million. Remaining restructuring and other charges (income) includes net miscellaneous charges of $6.3 million.

Twelve Months Ended December 31, 2014:

Restructuring and other charges (income) includes income of $26.6 million associated with a sale of a partial stake in our 20% owned European based distribution company offset by a charge of $22.0 million associated with various license agreements entered into for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development both of which pertain our FMC Agricultural Solutions segment. Additionally, this amount includes charges of $13.9 million associated with a reorganization of our Health and Nutrition segment and continuing environmental sites treated as a Corporate charge of $43.7 million. Remaining restructuring and other charges (income) includes net miscellaneous charges of $3.5 million.

(b) 

Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our Adjusted Earnings results noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

(c)

There were no charges for the twelve months ended December 31, 2015. On September 8, 2014, we announced that we will no longer proceed with the planned separation as a result of the planned acquisition of Cheminova A/S and divestiture of our FMC Alkali Chemicals division. Business separation costs for the three and twelve months ended December 31, 2014 represent charges associated with the planned separation activities through September 8, 2014.

(d)  

Charges related to the expensing of the inventory fair value step-up resulting from the application of acquisition accounting, legal and professional fees and gains or losses on hedging purchase price associated with the planned or completed acquisitions. Amounts represent the following:

Three Months Ended

Twelve Months Ended

December 31

December 31

(in Millions)

2015

2014

2015

2014

Acquisition-related charges - Cheminova A/S

Legal and professional fees ⁽¹⁾

$

6.6

$

16.9

$

60.4

$

32.2

Inventory fair value amortization ⁽²⁾

9.7

—

57.8

—

Loss/(gain) on hedging purchase price ⁽¹⁾

—

78.4

172.1

99.6

Acquisition-related charges - Epax

Inventory fair value amortization ⁽²⁾

—

—

—

4.2

Acquisition-related charges

$

16.3

$

95.3

$

290.3

$

136.0

____________________

(1)

On the condensed consolidated statements of income (loss), these charges are included in "Selling, general and administrative expenses."

(2)

On the condensed consolidated statements of income (loss), these charges are included in "Costs of sales and services."

(e) 

Three and Twelve Months Ended December 31, 2015

Discontinued operations includes our FMC Alkali Chemicals division as well as provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations. The twelve months ended December 31, 2015 includes the divestiture gain of approximately $700 million associated with the sale of FMC Alkali Chemicals division which was completed on April 1, 2015.

Three and Twelve Months Ended December 31, 2014

Discontinued operations includes our FMC Alkali and FMC Peroxygens business results as well as provisions, net of recoveries, for environmental liabilities and legal reserves and expenses related to previously discontinued operations. The twelve months ended December 31, 2014 includes the final divestiture charge associated with the sale of FMC Peroxygens business which was completed on February 28, 2014.

(f)   

We exclude the GAAP tax provision, including discrete items, from the Non-GAAP measure of income, and instead include a Non-GAAP tax provision based upon the annual Non-GAAP effective tax rate. The GAAP tax provision includes certain discrete tax items including, but are not limited to: income tax expenses or benefits that are not related to ongoing business operations in the current year; unusual or infrequently occurring items; tax adjustments associated with fluctuations in foreign currency remeasurement of certain foreign operations; certain changes in estimates of tax matters related to prior fiscal years; certain changes in the realizability of deferred tax assets; and changes in tax law. Management believes excluding these discrete tax items assists investors and securities analysts in understanding the tax provision and the effective tax rate related to ongoing operations thereby providing investors with useful supplemental information about FMC's operational performance.

Three Months Ended

Twelve Months Ended

December 31

December 31

(in Millions)

2015

2014

2015

2014

Non-GAAP tax adjustments:

Revisions to our tax liabilities due to finalization of prior year tax returns

$

2.1

$

(2.3)

$

2.2

$

(2.5)

Revisions to valuation allowances of historical deferred tax assets

120.7

—

128.3

—

Foreign currency remeasurement and foreign currency discrete items

(3.8)

(6.1)

(35.2)

(11.3)

Non-GAAP tax adjustments

$

119.0

$

(8.4)

$

95.3

$

(13.8)

RECONCILIATION OF NET INCOME (LOSS) (GAAP) TO ADJUSTED EARNINGS FROM

CONTINUING OPERATIONS, BEFORE INTEREST AND INCOME TAXES (NON-GAAP)

(Unaudited, in millions)

Three Months Ended

Twelve Months Ended

December 31

December 31

2015

2014

2015

2014

Net income (loss) (GAAP)

$

(202.7)

$

78.3

$

498.5

$

322.1

Restructuring and other charges (income)

165.8

11.5

244.0

56.4

Non-operating pension and postretirement charges

15.4

2.1

35.3

10.5

Business separation costs

—

—

—

23.6

Acquisition-related charges

16.3

95.3

290.3

136.0

Discontinued operations, net of income taxes

22.4

(19.4)

(676.4)

(14.5)

Interest expense, net

21.2

13.6

80.1

51.2

Provision (benefit) for income taxes

103.8

(18.4)

47.4

56.2

Adjusted earnings from continuing operations,
    before interest, income taxes and noncontrolling interests
    (Non-GAAP) ⁽¹⁾

$

142.2

$

163.0

$

519.2

$

641.5

___________________

(1)

Referred to as Adjusted Operating Profit.

FMC CORPORATION

INDUSTRY SEGMENT DATA

(Unaudited, in millions)

Three Months Ended

Twelve Months Ended

December 31

December 31

2015

2014

2015

2014

Revenue

FMC Agricultural Solutions

$

657.3

$

626.9

$

2,252.9

$

2,173.8

FMC Health and Nutrition

172.0

191.8

785.5

828.2

FMC Lithium

70.0

69.1

238.1

256.7

Total

$

899.3

$

887.8

$

3,276.5

$

3,258.7

Income from continuing operations before income taxes

FMC Agricultural Solutions

101.3

130.3

363.9

497.8

FMC Health and Nutrition

46.2

44.2

194.7

187.9

FMC Lithium

11.1

7.8

23.0

27.2

Segment operating profit ^(a)

158.6

182.3

581.6

712.9

Corporate and other

(16.4)

(19.3)

(62.4)

(71.4)

Adjusted earnings from continuing operations, before interest, income
taxes and noncontrolling interests (Non-GAAP)

$

142.2

$

163.0

$

519.2

$

641.5

Interest expense, net

(21.2)

(13.6)

(80.1)

(51.2)

Corporate special (charges) income:

Restructuring and other (charges) income ^(b)

(165.8)

(11.5)

(244.0)

(56.4)

Non-operating pension and postretirement charges ^(c)

(15.4)

(2.1)

(35.3)

(10.5)

Business separation charges ^(d)

—

—

—

(23.6)

Acquisition-related charges ^(e)

(16.3)

(95.3)

(290.3)

(136.0)

(Provision) benefit for income taxes

(103.8)

18.4

(47.4)

(56.2)

Discontinued operations, net of income taxes ^(f)

(22.4)

19.4

676.4

14.5

Net income attributable to noncontrolling interests

(1.4)

(1.8)

(9.5)

(14.6)

Net income (loss) attributable to FMC stockholders

$

(204.1)

$

76.5

$

489.0

$

307.5

____________________

(a)

Referred to as Segment Earnings.

(b)

Below provides the details of restructuring and other charges (income) by segment.

Three Months Ended December 31

Twelve Months Ended December 31

2015

2014

2015

2014

FMC Agricultural Solutions

$

(76.5)

$

21.5

$

(123.7)

$

4.5

FMC Health and Nutrition

(73.2)

(8.2)

(93.8)

(14.1)

FMC Lithium

(2.2)

—

(2.7)

—

Corporate

(13.9)

(24.8)

(23.8)

(46.8)

Restructuring and other (charges) income

$

(165.8)

$

(11.5)

$

(244.0)

$

(56.4)

(c) 

See Note (b) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(d) 

See Note (c) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(e) 

See Note (d) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

(f)  

See Note (e) to the schedule "Reconciliation of Net Income (Loss) Attributable to FMC Stockholders (GAAP) to Adjusted After-Tax Earnings from Continuing Operations, Attributable to FMC Stockholders (Non-GAAP)" for further details on the components that make up this line item.

FMC CORPORATION

FMC AGRICULTURAL SOLUTIONS PRO FORMA FINANCIAL RESULTS

(Unaudited, in millions)

In the second quarter of 2015, we began to present pro forma combined results for the FMC Agricultural Solutions segment for 2015 and 2014. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for 2015 and 2014 is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of this segment. Our pro forma segment information will include adjustments as if the Cheminova transaction had occurred on January 1, 2014. Our pro forma data will also be adjusted for the effects of acquisition accounting but will not include adjustments for cost related to integration activities, cost savings or synergies that might be achieved by the combined businesses. Pro forma amounts to be presented will not necessarily be indicative of what our results would have been had we operated Cheminova since January 1, 2014, nor our future results. We believe that reviewing our operating results by combining actual and pro forma results for the FMC Agricultural Solutions segment for these periods is more useful in identifying trends in, or reaching conclusions regarding, the overall operating performance of the segment.

FMC Agricultural Solutions Pro Forma Financial Results

Three Months Ended December 31

Twelve Months Ended December 31

(in Millions)

2015

2014

2015

2014

Revenue

Revenue, FMC Agricultural Solutions, as reported ⁽¹⁾

$

657.3

$

626.9

$

2,252.9

$

2,173.8

Revenue, Cheminova, pro forma ⁽²⁾

—

226.6

362.0

1,225.7

Pro Forma Combined, Revenue ⁽³⁾

$

657.3

$

853.5

$

2,614.9

$

3,399.5

Operating Profit

Operating Profit, FMC Agricultural Solutions, as reported ⁽¹⁾

$

101.3

$

130.3

$

363.9

$

497.8

Operating Profit, Cheminova, pro forma ⁽²⁾

—

(19.9)

19.9

38.2

Pro Forma Combined, Operating Profit ⁽³⁾

$

101.3

$

110.4

$

383.8

$

536.0

___________________

(1)

As reported amounts are the results of operations of FMC Agricultural Solutions, including the results of the Cheminova acquisition from April 21, 2015 onward.

(2)

Cheminova pro forma amounts include the historical results of Cheminova, prior to April 21, 2015. These amounts also include adjustments as if the Cheminova transaction had occurred on January 1, 2014, including the effects of acquisition accounting. The pro forma amounts do not include adjustments for expenses related to integration activities, cost savings or synergies that may have been or may be achieved by the combined segment. 

(3)

The pro forma combined amounts are not necessarily indicative of what the results would have been had we acquired Cheminova on January 1, 2014 or indicative of future results.

FMC CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in millions)

December 31, 2015

December 31, 2014

Cash and cash equivalents

$

78.6

$

109.5

Trade receivables, net

1,851.4

1,602.5

Inventories

800.2

607.6

Other current assets

241.7

188.8

Deferred income taxes

—

222.7

Current assets held for sale

—

203.3

Total current assets

2,971.9

2,934.4

Property, plant and equipment, net

1,016.4

930.0

Goodwill

776.1

352.5

Other intangibles, net

837.0

246.9

Deferred income taxes

286.9

200.1

Other long-term assets

437.6

260.6

Noncurrent assets held for sale

—

401.5

Total assets

$

6,325.9

$

5,326.0

Short-term debt and current portion of long-term debt

$

112.6

$

525.2

Accounts payable, trade and other

403.6

378.3

Accrued customer rebates

256.1

236.0

Guarantees of vendor financing

67.2

50.2

Accrued pensions and other postretirement benefits, current

6.4

12.7

Other current liabilities

607.4

619.6

Current liabilities held for sale

—

88.4

Total current liabilities

1,453.3

1,910.4

Long-term debt

2,036.3

1,138.9

Long-term liabilities

928.0

708.0

Long-term liabilities held for sale

—

4.7

Equity

1,908.3

1,564.0

Total liabilities and equity

$

6,325.9

$

5,326.0

FMC CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in millions)

Twelve Months Ended December 31

2015

2014

Cash provided (required) by operating activities of continuing operations ⁽¹⁾

$

(277.1)

$

284.9

Cash provided (required) by operating activities of discontinued operations

(80.6)

88.8

Cash provided (required) by investing activities of continuing operations

(1,285.5)

(190.2)

Cash provided (required) by investing activities of discontinued operations

1,634.3

154.9

Cash provided (required) by financing activities of continuing operations:

Increase (decrease) in short-term debt

(547.3)

(139.6)

Financing fees

—

(10.5)

Repayments of long-term debt

(1,036.6)

(34.6)

Proceeds from borrowings of long-term debt

1,650.0

3.0

Net distributions to and acquisitions of noncontrolling interests

—

(98.7)

Dividends paid

(86.4)

(78.1)

Other repurchases of common stock

(3.7)

(4.7)

Excess tax benefits from share-based compensation

1.4

4.7

Issuances of common stock, net

5.9

8.6

Cash provided (required) by financing activities

(16.7)

(349.9)

Effect of exchange rate changes on cash

(5.3)

(2.2)

Increase (decrease) in cash and cash equivalents

(30.9)

(13.7)

Cash and cash equivalents, beginning of year

109.5

123.2

Cash and cash equivalents, end of period

$

78.6

$

109.5

______________

(1)

The twelve months ended December 31, 2015 includes $264.8 million in payments associated with the Cheminova acquisition purchase price hedges and approximately $340.3 million in income tax payments principally driven by the sale of our Alkali Chemicals business.